Results 61 to 70 of about 62,042 (258)

T cells, the Next Big Target in Axial Spondyloarthritis?

open access: yesArthritis &Rheumatology, EarlyView.
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley   +1 more source

The comparison of effects of balneotherapy, water-based and land-based exercises on disease activity, symptoms, sleep quality, quality of life and serum sclerostin level in patients with ankylosing spondylitis: A prospective, randomized study

open access: yesThe Turkish Journal of Gastroenterology, 2022
Objectives: This study aims to compare the effects of balneotherapy, water-based exercise (WBE), and land-based exercise (LBE) on disease activity, symptoms, sleep quality, quality of life, and serum sclerostin level (SSL) in patients with ankylosing ...
Ersin Bestaş   +4 more
doaj  

Coexistence of ankylosing spondylitis and discoid lupus: A case report

open access: yesİstanbul Kuzey Klinikleri, 2019
Coexistence of ankylosing spondylitis with connective tissue diseases is very rare. Here, in this study, we describe a coexistence of ankylosing spondylitis and discoid lupus erythematosus in a 35-year-old man.
Ayşe Ünal Enginar   +2 more
doaj   +1 more source

Summary data ankylosing spondylitis GWAS

open access: yes
Summary of association tests for Nature Genetics publication "Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci"
International Genetics of Ankylosing Spondylitis Consortium (IGAS)
core   +1 more source

Deep Immunophenotyping Reveals Distinct Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are overlapping yet distinct conditions within the SpA spectrum. As divergent immunophenotypes may influence disease course and therapeutic response, we compared immune cell subsets, cytokine profiles, and inflammatory mediators.
Natalie Frede   +11 more
wiley   +1 more source

The Effect of Anti-Tumor Necrosis Factor-Alpha Treatment on Muscle Performance and Endurance in Patients With Ankylosing Spondylitis: A Prospective Follow-Up Study

open access: yesThe Turkish Journal of Gastroenterology, 2017
Objectives: This study aims to evaluate muscle performance by using isokinetic dynamometer before and at third month of anti-tumor necrosis factor-alpha treatment in ankylosing spondylitis patients. Patients and methods: Thirty ankylosing spondylitis
Musa DEMİRKAPI   +3 more
doaj  

Airway Management in Ankylosing Spondylitis with Intubating Laryngeal Mask Airway - A Case Report [PDF]

open access: yes, 2006
Patients of Ankylosing Spondylitis (AS) are difficult to intubate as a result of cervical spine rigidity; leading to inadequate extension of head and nonalignment of oral/pharyngeal and laryngeal planes.
Dr. Veena Asthana / Dr. Sanjay Agrawal/ Dr. D K Singh/ Dr. J P Sharma
core  

Genetics of ankylosing spondylitis

open access: yes, 2014
Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects the spine and sacroiliac joints. It causes significant disability and is associated with a number of other features including peripheral arthritis, anterior uveitis, psoriasis ...
Brown, Matthew A., Robinson, Philip C.
core   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety Up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week, double‐blind, placebo‐controlled, phase 3 Program for Evaluation
Philip J. Mease   +20 more
wiley   +1 more source

Factors affecting employment in Japanese patients with ankylosing spondylitis (AS)

open access: yesBMC Rheumatology
Background Ankylosing spondylitis (AS) often affects individuals during their most productive working years. However, few studies have investigated factors influencing employment in Japanese AS patients.
Hoshiko Furusawa   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy